Thales to purchase CMT Medical shares for almost $30M
Thales stretches further into medical imaging market with takeover of DR company. Image Source: CMT Medical Technologies  
CMT Medical Technologies’ board of directors have approved an offer made by Thales Group, an electronics and systems company, to purchase 50.1 percent to 100 percent of CMT shares for approximately $29.3 million (€21.5 million).

The Yoqneam Ilit, Israel-based CMT, a developer of high-resolution digital imaging solutions, will become an entity in the Thales Group and business line, augmenting the company’s portfolio in the medical imaging sector with new products and pipeline potential. Thales is a manufacturer of components and subsystems for professional applications, including hardware and software for medical radiology equipment.

"This offer by Thales, in line with the long-term strategic plan outlined for CMT, will enable us to secure our leadership in the field of medical imaging by leveraging our R&D strengths with Thales' technological knowledge, as well as by opening new, much broader channels for sales and distribution of our products worldwide,” said Amit Meridor, CEO of CMT.